Clinical trial Recruiting at 1 site Interventional Ages 18 to 59

Effects of a caregiver's physical contact on ICU patients

Official title: Physiological Changes in Adult Intensive Care Patients Upon Contact With Their Primary Caregiver (CARE-ICU): A Randomized Clinical Trial

Run by Universidad Autonoma del Estado de Mexico · NCT07761364 · Data updated 2026-11-12

This study tests whether brief physical contact from a patient’s primary caregiver can influence vital signs in adults in intensive care.

More Critical Illness trials

Quick facts

Study typeInterventional
Ages18 Years to 59 Years
SexAll
Enrollment80 (estimated)
SponsorUniversidad Autonoma del Estado de Mexico
Academic / other
Locations1 site (Mexico City, Mexico City)
StatusRecruiting
StartedAugust 1, 2026
Main results expectedAugust 31, 2026
Study endsAugust 31, 2026
Registry record updatedAugust 12, 2026
Trial IDNCT07761364 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults 18 years or older in the ICU for 24–48 hours with stable sedation (RASS -3 to -1 or 0 to +3) and a GCS > 13, with an identified primary caregiver who can participate and consent.

Probably not a fit

Patients with neurological disorders, MODS, unstable arrhythmias, fever, or hypertension at assessment may not benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This randomized, parallel-group trial compares standardized therapeutic physical contact from the patient’s primary caregiver to a control condition with no such contact in adult ICU patients. Participants are randomly assigned in a 1:1 ratio with allocation concealment, and outcomes are measured at three time points around the caregiver visit using bedside monitoring. The study focuses on physiological parameters such as heart rate, blood pressure, respiratory rate, oxygen saturation, and temperature to see if caregiver interaction affects these measures. Eligible patients are adults in the ICU for 24–48 hours with specific sedation and consciousness criteria, and their identified primary caregiver must participate under informed consent. The trial is conducted at the Instituto Nacional de Enfermedades Respiratorias with the Universidad Autonoma del Estado de Mexico as lead sponsor.

Why it matters

Potential benefit: If successful, patients may experience improved physiological stability during caregiver interactions in the ICU.

How similar studies have gone: Prior studies on caregiver involvement in critical care have shown mixed results; this trial tests a specific, standardized contact intervention in a rigorous RCT design.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria

Patient Criteria:

* Adults aged 18 years or older.
* Admission to the intensive care unit (ICU) for 24 to 48 hours.
* Richmond Agitation-Sedation Scale (RASS) score between -3 and -1 or between 0 and +3.
* Glasgow Coma Scale score greater than 13.

Primary Caregiver Criteria:

* Identified as the patient's primary caregiver.
* Willing and able to participate in the study.
* Provides written informed consent prior to study participation.

Exclusion Criteria

Patient Criteria:

* Diagnosis of a neurological disorder (e.g., cerebrovascular disease or stroke).
* Multiple organ dysfunction syndrome (MODS).
* Unstable or difficult-to-control cardiac arrhythmias.
* Fever (body temperature ≥ 37.5°C) at the time of assessment.
* Hypertension (blood pressure ≥ 130/80 mmHg) at the time of assessment.

Primary Caregiver Criteria:

\- Unable to be present to perform the intervention according to the study protocol.

Where it's running

  • Investigación del Instituto Nacional de Enfermedades Respiratorias
    Mexico City, Mexico City, Mexico
    Recruiting

Study contacts

  • Principal investigator: Isabel Álvarez-Solorza, RN, PhD — Universidad Autonoma del Estado de Mexico
  • Study coordinator: Isabel Álvarez-Solorza, Dr.
  • Email: ialvarezs@uaemex.mx
  • Phone: +52 1 7222231161

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.